Abstract: Microarray chip technology has met the challenges of traditional fluorescent labeling in terms of high cost and low detection efficiency , and provides a high-throughput and cost-effective ...

Starting this week, ADN has a new full-time opinion editor. Gary Black is joining us from the Fairbanks Daily News-Miner, where he was managing editor for the past five years. He was with the ...

Abstract: Microarray image processing leads to the characterization of gene expression levels simultaneously, for all cellular transcripts (mRNAs) in a single experiment. The calculation of expression ...

Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...

The clinical study aims to evaluate a vaccine for avian influenza A (H7N9) delivered by Vaxxas’ high-density microarray patch (HD-MAP), and is funded by the United States government as a potential ...

The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses. The phase 1/2 randomized trial compared results from the ...

The $1-billion plant to produce the chemical ADN—a nylon precursor—was the client’s largest-ever capital investment. The team overcame supply chain challenges, COVID-19 lockdowns and typhoons to ...

Tissue microarrays combines tens to hundreds of paraffin-embedded tissue cores into a single paraffin block. It is a practical and highly effective technique for high-throughput analyses of various ...

Spectrum Solutions’ offerings enhanced by including CLIA/CAP laboratory testing, custom assay development, and manufacturing of industry-leading microarray chip technology. These valuable assets, ...

Launched in 1990, The Human Genome Project was a monumental effort to sequence and analyze the entire human genome to understand how genetics influence health. While the Human Genome Project helped ...